UNSPSC 85532272: Bypass right greater saphenous vein to lower vein with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass right greater saphenous vein to lower vein with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 061P4KY

UNSPSC 85532272, Bypass right greater saphenous vein to lower vein with nonautologous tissue substitute, percutaneous endoscopic approach, is a Commodity code that does not align with state and local procurement activity in the available recent opportunities. The code describes a specific surgical procedure — a vascular bypass grafting technique — yet the six state and local solicitations posted between July and September 2026 and tagged under this code all procure health services administration, occupational medical surveillance, pharmacy benefit management, temporary clinical staffing, and independent medical evaluation services. None of these opportunities solicit actual surgical procedures, vascular grafts, or tissue substitutes. The mismatch suggests either a systematic coding error at the source level or that this code is being applied to procurements where a different UNSPSC category would be more precise.

The recent opportunities show activity from diverse issuing bodies — two county health systems (Santa Clara, Collier), two cities (Phoenix, Long Beach), one state transportation agency (Washington State Department of Transportation on behalf of the Washington State Ferries), and one county juvenile justice department (Harris County) — all pursuing health services contracts rather than surgical supplies or procedures. Geographic spread includes California, Arizona, Florida, Washington, and Texas. If this code is intended to track state and local procurement of vascular bypass grafts and associated implants for use in surgical programs, no such activity appears in the current opportunity stream; buyers pursuing those supplies would likely use a different UNSPSC classification.